Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
11 October 2021 |
Main ID: |
NCT03187613 |
Date of registration:
|
13/06/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Correlation of Metamorphopsia and Aniseikonia to Retinal Shift Following Retinal Detachment Surgery
|
Scientific title:
|
Correlation of Metamorphopsia and Aniseikonia to Retinal Shift Following Retinal Detachment Surgery |
Date of first enrolment:
|
June 21, 2017 |
Target sample size:
|
38 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03187613 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Norway
| | | | | | | |
Contacts
|
Name:
|
Vegard Forsaa, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Helse Stavanger HF |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Acute rhegmatogenous retinal detachment, fovea detached, able to signe
Exclusion Criteria:
- Secondary retinal detachment like tractional, serous or with ora serrata dialysis,
fovea on
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Retinal Detachment
|
Primary Outcome(s)
|
Retinal shift
[Time Frame: 2 years]
|
Secondary Outcome(s)
|
Visual acuity
[Time Frame: 6 and 24 months]
|
Aniseikonia
[Time Frame: 6 and 24 months]
|
Metamorphopsia
[Time Frame: 6 and 24 months]
|
Stereopsis
[Time Frame: 6 and 24 months]
|
Secondary ID(s)
|
2017/730 REK
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|